Olivo Alicia C 4

What Happened

• Alicia C. Olivo, EVP, General Counsel & Business Development of Neogenomics (NEO), disposed of 1,042 shares on May 1, 2026 as payment of a tax liability (transaction code F). The transaction shows an acquisition/transfer price of $0.00 and no cash proceeds — this indicates shares were withheld to satisfy taxes rather than sold on the open market. The Form 4 was filed on May 5, 2026.

Key Details

• Transaction date: 2026-05-01; Form 4 filed: 2026-05-05 (timely filing).
• Transaction type/code: F — Payment of exercise price or tax liability (share withholding).
• Shares involved: 1,042 shares; per-share price reported as $0.00; total cash proceeds $0.
• Shares owned after transaction: not stated in the provided excerpt of the filing.
• Relevant footnotes: the filing includes numerous footnotes (F1–F19) documenting prior option, RSU and PSU grants and their vesting schedules (grants from 2019–2026). See those footnotes for the awards that likely triggered the tax withholding.

Context

• A payment coded “F” typically means the insider surrendered shares to cover withholding taxes on vested awards or exercised options (a routine administrative step), not an open-market sale that signals intent to liquidate. This is common after RSU vesting or option exercises and does not provide a directional market signal.